is there a shortage of semaglutide 📢 FDA has determined the injection products, glucagon-like peptide 1 (GLP-1) medication, resolved. Patients and prescribers may still see intermittent and limited localized supply disruptions as the Federal judge upholds FDA's removal

The relationship among GSH depletion, ferroptosis, and senescence has not been reported

The Endocrine Society presented data at ENDO 2025 showing that women and older adults on semaglutide face the highest risk of muscle loss, but that higher protein intake significantly reduced this risk

Alu A, et al

Service is efficient, friendly and they are extremely responsive to questions and requests

Thursday, 27 November 2025 08:00 AM Umbrella Labs Announces Forthcoming Retatrutide Endocrine Dynamics Research Program To Advance Mechanistic Non-Clinical Science Thursday, 27 November 2025 08:00 AM Company Update TUCSON, AZ / ACCESS Newswire / November 27, 2025 / Umbrella Labs today announced the development of a multi-phase, non-clinical research program centered on Retatrutide (LY-3437943), designed to characterize peptide behavior, assay performance, and endocrine-signaling dynamics in laboratory models with a level of rigor typically reserved for peer-reviewed translational work